| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,088 |
13,254 |
$1.00M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,923 |
4,462 |
$420K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,859 |
1,857 |
$143K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,758 |
1,753 |
$134K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,711 |
3,515 |
$112K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,575 |
3,381 |
$95K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,251 |
1,215 |
$87K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,284 |
5,912 |
$85K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
851 |
847 |
$71K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,369 |
1,315 |
$46K |
| 99058 |
|
1,684 |
1,559 |
$45K |
| 92551 |
|
2,890 |
2,872 |
$28K |
| 92552 |
|
884 |
869 |
$27K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,866 |
2,845 |
$25K |
| 99000 |
|
4,620 |
4,306 |
$17K |
| 90651 |
|
277 |
274 |
$14K |
| 90680 |
|
735 |
727 |
$12K |
| 99215 |
Prolong outpt/office vis |
89 |
69 |
$11K |
| 90633 |
|
770 |
765 |
$10K |
| 96127 |
|
1,990 |
1,968 |
$10K |
| 90670 |
|
667 |
661 |
$10K |
| 90671 |
|
241 |
238 |
$10K |
| 90677 |
|
259 |
258 |
$9K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,424 |
4,328 |
$9K |
| 99177 |
|
2,208 |
2,196 |
$9K |
| 90698 |
|
894 |
884 |
$8K |
| 90744 |
|
605 |
597 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
82 |
81 |
$6K |
| 90710 |
|
155 |
155 |
$6K |
| 99173 |
|
2,263 |
2,246 |
$5K |
| 99383 |
|
50 |
50 |
$4K |
| 99442 |
|
70 |
64 |
$4K |
| 90649 |
|
134 |
134 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
410 |
376 |
$4K |
| 90686 |
|
252 |
251 |
$3K |
| 90620 |
|
83 |
83 |
$3K |
| 90658 |
|
302 |
300 |
$3K |
| 90461 |
|
2,378 |
2,356 |
$3K |
| 90716 |
|
111 |
111 |
$3K |
| 90707 |
|
143 |
143 |
$2K |
| 90674 |
|
159 |
159 |
$2K |
| 90700 |
|
165 |
165 |
$2K |
| 87807 |
|
168 |
157 |
$2K |
| 90715 |
|
101 |
100 |
$1K |
| 99384 |
|
14 |
14 |
$1K |
| 99381 |
|
13 |
13 |
$1K |
| 90648 |
|
96 |
96 |
$1K |
| 90696 |
|
136 |
136 |
$996.93 |
| 99402 |
|
23 |
16 |
$852.60 |
| A4617 |
Mouth piece |
243 |
218 |
$703.50 |
| A7015 |
Aerosol mask, used with dme nebulizer |
412 |
378 |
$510.23 |
| A7004 |
Small volume nonfiltered pneumatic nebulizer, disposable |
255 |
230 |
$436.75 |
| 94664 |
|
253 |
228 |
$85.90 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
283 |
254 |
$55.33 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
32 |
31 |
$6.72 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
46 |
44 |
$0.10 |
| 90734 |
|
271 |
268 |
$0.00 |
| 91300 |
|
384 |
370 |
$0.00 |
| 0002A |
|
145 |
145 |
$0.00 |
| 99404 |
|
45 |
33 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
16 |
15 |
$0.00 |
| 0001A |
|
178 |
176 |
$0.00 |